 | • レポートコード：QFJ1-4065 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、CRISPR＆Cas遺伝子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベクターベースCas、DNAフリーCas、細胞株工学）、用途別市場規模（バイオテクノロジー＆製薬会社、学術＆政府研究所、委託研究機関（CRO））、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・CRISPR＆Cas遺伝子の市場動向 ・企業の競争状況、市場シェア ・CRISPR＆Cas遺伝子の種類別市場規模と予測2016-2027（ベクターベースCas、DNAフリーCas、細胞株工学） ・CRISPR＆Cas遺伝子の用途別市場規模と予測2016-2027（バイオテクノロジー＆製薬会社、学術＆政府研究所、委託研究機関（CRO）） ・CRISPR＆Cas遺伝子の北米市場規模2016-2027（アメリカ、カナダ） ・CRISPR＆Cas遺伝子の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・CRISPR＆Cas遺伝子のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・CRISPR＆Cas遺伝子の中南米市場規模2016-2027（メキシコ、ブラジル） ・CRISPR＆Cas遺伝子の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（CRISPR Therapeutics、AstraZeneca、Addgene、Caribou Biosciences, Inc.、Cellectis、Editas Medicine, Inc.、Egenesis、F. Hoffmann-La Roche Ltd.、Horizon Discovery Group Plc、Genscrip、Danaher Corporation、Intellia Therapeutics, Inc.、Lonza、Merck KGaA、New England BioLabs、Takara Bio, Inc.、Synthego、Mammoth Biosciences、Inscripta, Inc.、Cibus） ・結論 |
CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to detect and destroy DNA from similar bacteriophages during subsequent infections. Hence these sequences play a key role in the antiviral (i.e. anti-phage) defense system of prokaryotes.
Cas9 (or “CRISPR-associated protein 9”) is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms. This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases.
Diagram of the CRISPR prokaryotic antiviral defense mechanism. The CRISPR-Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages and provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA.
Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.
Market Analysis and Insights: Global CRISPR & Cas Genes Market
The global CRISPR & Cas Genes market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRISPR & Cas Genes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRISPR & Cas Genes market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRISPR & Cas Genes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRISPR & Cas Genes market.
Global CRISPR & Cas Genes Scope and Market Size
CRISPR & Cas Genes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR & Cas Genes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Vector-based Cas
DNA-free Cas
Cell Line Engineering
Segment by Application
Biotechnology and Pharmaceutical Companies
Academics and Government Research Institutes
Contract Research Organizations (CROs)
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
CRISPR Therapeutics
AstraZeneca
Addgene
Caribou Biosciences, Inc.
Cellectis
Editas Medicine, Inc.
Egenesis
F. Hoffmann-La Roche Ltd.
Horizon Discovery Group Plc
Genscrip
Danaher Corporation
Intellia Therapeutics, Inc.
Lonza
Merck KGaA
New England BioLabs
Takara Bio, Inc.
Synthego
Mammoth Biosciences
Inscripta, Inc.
Cibus
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR & Cas Genes Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vector-based Cas
1.2.3 DNA-free Cas
1.2.4 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR & Cas Genes Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academics and Government Research Institutes
1.3.4 Contract Research Organizations (CROs)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CRISPR & Cas Genes Market Perspective (2016-2027)
2.2 CRISPR & Cas Genes Growth Trends by Regions
2.2.1 CRISPR & Cas Genes Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CRISPR & Cas Genes Historic Market Share by Regions (2016-2021)
2.2.3 CRISPR & Cas Genes Forecasted Market Size by Regions (2022-2027)
2.3 CRISPR & Cas Genes Industry Dynamic
2.3.1 CRISPR & Cas Genes Market Trends
2.3.2 CRISPR & Cas Genes Market Drivers
2.3.3 CRISPR & Cas Genes Market Challenges
2.3.4 CRISPR & Cas Genes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR & Cas Genes Players by Revenue
3.1.1 Global Top CRISPR & Cas Genes Players by Revenue (2016-2021)
3.1.2 Global CRISPR & Cas Genes Revenue Market Share by Players (2016-2021)
3.2 Global CRISPR & Cas Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRISPR & Cas Genes Revenue
3.4 Global CRISPR & Cas Genes Market Concentration Ratio
3.4.1 Global CRISPR & Cas Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR & Cas Genes Revenue in 2020
3.5 CRISPR & Cas Genes Key Players Head office and Area Served
3.6 Key Players CRISPR & Cas Genes Product Solution and Service
3.7 Date of Enter into CRISPR & Cas Genes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR & Cas Genes Breakdown Data by Type
4.1 Global CRISPR & Cas Genes Historic Market Size by Type (2016-2021)
4.2 Global CRISPR & Cas Genes Forecasted Market Size by Type (2022-2027)
5 CRISPR & Cas Genes Breakdown Data by Application
5.1 Global CRISPR & Cas Genes Historic Market Size by Application (2016-2021)
5.2 Global CRISPR & Cas Genes Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America CRISPR & Cas Genes Market Size (2016-2027)
6.2 North America CRISPR & Cas Genes Market Size by Type
6.2.1 North America CRISPR & Cas Genes Market Size by Type (2016-2021)
6.2.2 North America CRISPR & Cas Genes Market Size by Type (2022-2027)
6.2.3 North America CRISPR & Cas Genes Market Size by Type (2016-2027)
6.3 North America CRISPR & Cas Genes Market Size by Application
6.3.1 North America CRISPR & Cas Genes Market Size by Application (2016-2021)
6.3.2 North America CRISPR & Cas Genes Market Size by Application (2022-2027)
6.3.3 North America CRISPR & Cas Genes Market Size by Application (2016-2027)
6.4 North America CRISPR & Cas Genes Market Size by Country
6.4.1 North America CRISPR & Cas Genes Market Size by Country (2016-2021)
6.4.2 North America CRISPR & Cas Genes Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe CRISPR & Cas Genes Market Size (2016-2027)
7.2 Europe CRISPR & Cas Genes Market Size by Type
7.2.1 Europe CRISPR & Cas Genes Market Size by Type (2016-2021)
7.2.2 Europe CRISPR & Cas Genes Market Size by Type (2022-2027)
7.2.3 Europe CRISPR & Cas Genes Market Size by Type (2016-2027)
7.3 Europe CRISPR & Cas Genes Market Size by Application
7.3.1 Europe CRISPR & Cas Genes Market Size by Application (2016-2021)
7.3.2 Europe CRISPR & Cas Genes Market Size by Application (2022-2027)
7.3.3 Europe CRISPR & Cas Genes Market Size by Application (2016-2027)
7.4 Europe CRISPR & Cas Genes Market Size by Country
7.4.1 Europe CRISPR & Cas Genes Market Size by Country (2016-2021)
7.4.2 Europe CRISPR & Cas Genes Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific CRISPR & Cas Genes Market Size (2016-2027)
8.2 Asia-Pacific CRISPR & Cas Genes Market Size by Type
8.2.1 Asia-Pacific CRISPR & Cas Genes Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CRISPR & Cas Genes Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CRISPR & Cas Genes Market Size by Type (2016-2027)
8.3 Asia-Pacific CRISPR & Cas Genes Market Size by Application
8.3.1 Asia-Pacific CRISPR & Cas Genes Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CRISPR & Cas Genes Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CRISPR & Cas Genes Market Size by Application (2016-2027)
8.4 Asia-Pacific CRISPR & Cas Genes Market Size by Region
8.4.1 Asia-Pacific CRISPR & Cas Genes Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CRISPR & Cas Genes Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America CRISPR & Cas Genes Market Size (2016-2027)
9.2 Latin America CRISPR & Cas Genes Market Size by Type
9.2.1 Latin America CRISPR & Cas Genes Market Size by Type (2016-2021)
9.2.2 Latin America CRISPR & Cas Genes Market Size by Type (2022-2027)
9.2.3 Latin America CRISPR & Cas Genes Market Size by Type (2016-2027)
9.3 Latin America CRISPR & Cas Genes Market Size by Application
9.3.1 Latin America CRISPR & Cas Genes Market Size by Application (2016-2021)
9.3.2 Latin America CRISPR & Cas Genes Market Size by Application (2022-2027)
9.3.3 Latin America CRISPR & Cas Genes Market Size by Application (2016-2027)
9.4 Latin America CRISPR & Cas Genes Market Size by Country
9.4.1 Latin America CRISPR & Cas Genes Market Size by Country (2016-2021)
9.4.2 Latin America CRISPR & Cas Genes Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR & Cas Genes Market Size (2016-2027)
10.2 Middle East & Africa CRISPR & Cas Genes Market Size by Type
10.2.1 Middle East & Africa CRISPR & Cas Genes Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CRISPR & Cas Genes Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CRISPR & Cas Genes Market Size by Type (2016-2027)
10.3 Middle East & Africa CRISPR & Cas Genes Market Size by Application
10.3.1 Middle East & Africa CRISPR & Cas Genes Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CRISPR & Cas Genes Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CRISPR & Cas Genes Market Size by Application (2016-2027)
10.4 Middle East & Africa CRISPR & Cas Genes Market Size by Country
10.4.1 Middle East & Africa CRISPR & Cas Genes Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CRISPR & Cas Genes Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 CRISPR Therapeutics
11.1.1 CRISPR Therapeutics Company Details
11.1.2 CRISPR Therapeutics Business Overview
11.1.3 CRISPR Therapeutics CRISPR & Cas Genes Introduction
11.1.4 CRISPR Therapeutics Revenue in CRISPR & Cas Genes Business (2016-2021)
11.1.5 CRISPR Therapeutics Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca CRISPR & Cas Genes Introduction
11.2.4 AstraZeneca Revenue in CRISPR & Cas Genes Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Addgene
11.3.1 Addgene Company Details
11.3.2 Addgene Business Overview
11.3.3 Addgene CRISPR & Cas Genes Introduction
11.3.4 Addgene Revenue in CRISPR & Cas Genes Business (2016-2021)
11.3.5 Addgene Recent Development
11.4 Caribou Biosciences, Inc.
11.4.1 Caribou Biosciences, Inc. Company Details
11.4.2 Caribou Biosciences, Inc. Business Overview
11.4.3 Caribou Biosciences, Inc. CRISPR & Cas Genes Introduction
11.4.4 Caribou Biosciences, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021)
11.4.5 Caribou Biosciences, Inc. Recent Development
11.5 Cellectis
11.5.1 Cellectis Company Details
11.5.2 Cellectis Business Overview
11.5.3 Cellectis CRISPR & Cas Genes Introduction
11.5.4 Cellectis Revenue in CRISPR & Cas Genes Business (2016-2021)
11.5.5 Cellectis Recent Development
11.6 Editas Medicine, Inc.
11.6.1 Editas Medicine, Inc. Company Details
11.6.2 Editas Medicine, Inc. Business Overview
11.6.3 Editas Medicine, Inc. CRISPR & Cas Genes Introduction
11.6.4 Editas Medicine, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021)
11.6.5 Editas Medicine, Inc. Recent Development
11.7 Egenesis
11.7.1 Egenesis Company Details
11.7.2 Egenesis Business Overview
11.7.3 Egenesis CRISPR & Cas Genes Introduction
11.7.4 Egenesis Revenue in CRISPR & Cas Genes Business (2016-2021)
11.7.5 Egenesis Recent Development
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Details
11.8.2 F. Hoffmann-La Roche Ltd. Business Overview
11.8.3 F. Hoffmann-La Roche Ltd. CRISPR & Cas Genes Introduction
11.8.4 F. Hoffmann-La Roche Ltd. Revenue in CRISPR & Cas Genes Business (2016-2021)
11.8.5 F. Hoffmann-La Roche Ltd. Recent Development
11.9 Horizon Discovery Group Plc
11.9.1 Horizon Discovery Group Plc Company Details
11.9.2 Horizon Discovery Group Plc Business Overview
11.9.3 Horizon Discovery Group Plc CRISPR & Cas Genes Introduction
11.9.4 Horizon Discovery Group Plc Revenue in CRISPR & Cas Genes Business (2016-2021)
11.9.5 Horizon Discovery Group Plc Recent Development
11.10 Genscrip
11.10.1 Genscrip Company Details
11.10.2 Genscrip Business Overview
11.10.3 Genscrip CRISPR & Cas Genes Introduction
11.10.4 Genscrip Revenue in CRISPR & Cas Genes Business (2016-2021)
11.10.5 Genscrip Recent Development
11.11 Danaher Corporation
11.11.1 Danaher Corporation Company Details
11.11.2 Danaher Corporation Business Overview
11.11.3 Danaher Corporation CRISPR & Cas Genes Introduction
11.11.4 Danaher Corporation Revenue in CRISPR & Cas Genes Business (2016-2021)
11.11.5 Danaher Corporation Recent Development
11.12 Intellia Therapeutics, Inc.
11.12.1 Intellia Therapeutics, Inc. Company Details
11.12.2 Intellia Therapeutics, Inc. Business Overview
11.12.3 Intellia Therapeutics, Inc. CRISPR & Cas Genes Introduction
11.12.4 Intellia Therapeutics, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021)
11.12.5 Intellia Therapeutics, Inc. Recent Development
11.13 Lonza
11.13.1 Lonza Company Details
11.13.2 Lonza Business Overview
11.13.3 Lonza CRISPR & Cas Genes Introduction
11.13.4 Lonza Revenue in CRISPR & Cas Genes Business (2016-2021)
11.13.5 Lonza Recent Development
11.14 Merck KGaA
11.14.1 Merck KGaA Company Details
11.14.2 Merck KGaA Business Overview
11.14.3 Merck KGaA CRISPR & Cas Genes Introduction
11.14.4 Merck KGaA Revenue in CRISPR & Cas Genes Business (2016-2021)
11.14.5 Merck KGaA Recent Development
11.15 New England BioLabs
11.15.1 New England BioLabs Company Details
11.15.2 New England BioLabs Business Overview
11.15.3 New England BioLabs CRISPR & Cas Genes Introduction
11.15.4 New England BioLabs Revenue in CRISPR & Cas Genes Business (2016-2021)
11.15.5 New England BioLabs Recent Development
11.16 Takara Bio, Inc.
11.16.1 Takara Bio, Inc. Company Details
11.16.2 Takara Bio, Inc. Business Overview
11.16.3 Takara Bio, Inc. CRISPR & Cas Genes Introduction
11.16.4 Takara Bio, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021)
11.16.5 Takara Bio, Inc. Recent Development
11.17 Synthego
11.17.1 Synthego Company Details
11.17.2 Synthego Business Overview
11.17.3 Synthego CRISPR & Cas Genes Introduction
11.17.4 Synthego Revenue in CRISPR & Cas Genes Business (2016-2021)
11.17.5 Synthego Recent Development
11.18 Mammoth Biosciences
11.18.1 Mammoth Biosciences Company Details
11.18.2 Mammoth Biosciences Business Overview
11.18.3 Mammoth Biosciences CRISPR & Cas Genes Introduction
11.18.4 Mammoth Biosciences Revenue in CRISPR & Cas Genes Business (2016-2021)
11.18.5 Mammoth Biosciences Recent Development
11.18 Inscripta, Inc.
.1 Inscripta, Inc. Company Details
.2 Inscripta, Inc. Business Overview
.3 Inscripta, Inc. CRISPR & Cas Genes Introduction
.4 Inscripta, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021)
.5 Inscripta, Inc. Recent Development
11.20 Cibus
11.20.1 Cibus Company Details
11.20.2 Cibus Business Overview
11.20.3 Cibus CRISPR & Cas Genes Introduction
11.20.4 Cibus Revenue in CRISPR & Cas Genes Business (2016-2021)
11.20.5 Cibus Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global CRISPR & Cas Genes Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vector-based Cas
Table 3. Key Players of DNA-free Cas
Table 4. Key Players of Cell Line Engineering
Table 5. Global CRISPR & Cas Genes Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global CRISPR & Cas Genes Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global CRISPR & Cas Genes Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global CRISPR & Cas Genes Market Share by Regions (2016-2021)
Table 9. Global CRISPR & Cas Genes Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global CRISPR & Cas Genes Market Share by Regions (2022-2027)
Table 11. CRISPR & Cas Genes Market Trends
Table 12. CRISPR & Cas Genes Market Drivers
Table 13. CRISPR & Cas Genes Market Challenges
Table 14. CRISPR & Cas Genes Market Restraints
Table 15. Global CRISPR & Cas Genes Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global CRISPR & Cas Genes Market Share by Players (2016-2021)
Table 17. Global Top CRISPR & Cas Genes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR & Cas Genes as of 2020)
Table 18. Ranking of Global Top CRISPR & Cas Genes Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by CRISPR & Cas Genes Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players CRISPR & Cas Genes Product Solution and Service
Table 22. Date of Enter into CRISPR & Cas Genes Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million)
Table 25. Global CRISPR & Cas Genes Revenue Market Share by Type (2016-2021)
Table 26. Global CRISPR & Cas Genes Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global CRISPR & Cas Genes Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global CRISPR & Cas Genes Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global CRISPR & Cas Genes Revenue Market Share by Application (2016-2021)
Table 30. Global CRISPR & Cas Genes Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global CRISPR & Cas Genes Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million)
Table 33. North America CRISPR & Cas Genes Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America CRISPR & Cas Genes Market Size by Application (2016-2021) (US$ Million)
Table 35. North America CRISPR & Cas Genes Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America CRISPR & Cas Genes Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America CRISPR & Cas Genes Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe CRISPR & Cas Genes Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe CRISPR & Cas Genes Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe CRISPR & Cas Genes Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe CRISPR & Cas Genes Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe CRISPR & Cas Genes Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific CRISPR & Cas Genes Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific CRISPR & Cas Genes Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific CRISPR & Cas Genes Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific CRISPR & Cas Genes Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific CRISPR & Cas Genes Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America CRISPR & Cas Genes Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America CRISPR & Cas Genes Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America CRISPR & Cas Genes Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America CRISPR & Cas Genes Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America CRISPR & Cas Genes Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa CRISPR & Cas Genes Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa CRISPR & Cas Genes Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa CRISPR & Cas Genes Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa CRISPR & Cas Genes Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa CRISPR & Cas Genes Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa CRISPR & Cas Genes Market Size by Country (2022-2027) & (US$ Million)
Table 62. CRISPR Therapeutics Company Details
Table 63. CRISPR Therapeutics Business Overview
Table 64. CRISPR Therapeutics CRISPR & Cas Genes Product
Table 65. CRISPR Therapeutics Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 66. CRISPR Therapeutics Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca CRISPR & Cas Genes Product
Table 70. AstraZeneca Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Addgene Company Details
Table 73. Addgene Business Overview
Table 74. Addgene CRISPR & Cas Genes Product
Table 75. Addgene Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 76. Addgene Recent Development
Table 77. Caribou Biosciences, Inc. Company Details
Table 78. Caribou Biosciences, Inc. Business Overview
Table 79. Caribou Biosciences, Inc. CRISPR & Cas Genes Product
Table 80. Caribou Biosciences, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 81. Caribou Biosciences, Inc. Recent Development
Table 82. Cellectis Company Details
Table 83. Cellectis Business Overview
Table 84. Cellectis CRISPR & Cas Genes Product
Table 85. Cellectis Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 86. Cellectis Recent Development
Table 87. Editas Medicine, Inc. Company Details
Table 88. Editas Medicine, Inc. Business Overview
Table 89. Editas Medicine, Inc. CRISPR & Cas Genes Product
Table 90. Editas Medicine, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 91. Editas Medicine, Inc. Recent Development
Table 92. Egenesis Company Details
Table 93. Egenesis Business Overview
Table 94. Egenesis CRISPR & Cas Genes Product
Table 95. Egenesis Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 96. Egenesis Recent Development
Table 97. F. Hoffmann-La Roche Ltd. Company Details
Table 98. F. Hoffmann-La Roche Ltd. Business Overview
Table 99. F. Hoffmann-La Roche Ltd. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 100. F. Hoffmann-La Roche Ltd. Recent Development
Table 101. Horizon Discovery Group Plc Company Details
Table 102. Horizon Discovery Group Plc Business Overview
Table 103. Horizon Discovery Group Plc CRISPR & Cas Genes Product
Table 104. Horizon Discovery Group Plc Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 105. Horizon Discovery Group Plc Recent Development
Table 106. Genscrip Company Details
Table 107. Genscrip Business Overview
Table 108. Genscrip CRISPR & Cas Genes Product
Table 109. Genscrip Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 110. Genscrip Recent Development
Table 111. Danaher Corporation Company Details
Table 112. Danaher Corporation Business Overview
Table 113. Danaher Corporation CRISPR & Cas Genes Product
Table 114. Danaher Corporation Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 115. Danaher Corporation Recent Development
Table 116. Intellia Therapeutics, Inc. Company Details
Table 117. Intellia Therapeutics, Inc. Business Overview
Table 118. Intellia Therapeutics, Inc. CRISPR & Cas Genes Product
Table 119. Intellia Therapeutics, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 120. Intellia Therapeutics, Inc. Recent Development
Table 121. Lonza Company Details
Table 122. Lonza Business Overview
Table 123. Lonza CRISPR & Cas Genes Product
Table 124. Lonza Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 125. Lonza Recent Development
Table 126. Merck KGaA Company Details
Table 127. Merck KGaA Business Overview
Table 128. Merck KGaA CRISPR & Cas Genes Product
Table 129. Merck KGaA Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 130. Merck KGaA Recent Development
Table 131. New England BioLabs Company Details
Table 132. New England BioLabs Business Overview
Table 133. New England BioLabs CRISPR & Cas Genes Product
Table 134. New England BioLabs Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 135. New England BioLabs Recent Development
Table 136. Takara Bio, Inc. Company Details
Table 137. Takara Bio, Inc. Business Overview
Table 138. Takara Bio, Inc. CRISPR & Cas Genes Product
Table 139. Takara Bio, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 140. Takara Bio, Inc. Recent Development
Table 141. Synthego Company Details
Table 142. Synthego Business Overview
Table 143. Synthego CRISPR & Cas Genes Product
Table 144. Synthego Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 145. Synthego Recent Development
Table 146. Mammoth Biosciences Company Details
Table 147. Mammoth Biosciences Business Overview
Table 148. Mammoth Biosciences CRISPR & Cas Genes Product
Table 149. Mammoth Biosciences Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 150. Mammoth Biosciences Recent Development
Table 151. Inscripta, Inc. Company Details
Table 152. Inscripta, Inc. Business Overview
Table 153. Inscripta, Inc. CRISPR & Cas Genes Product
Table 154. Inscripta, Inc. Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 155. Inscripta, Inc. Recent Development
Table 156. Cibus Company Details
Table 157. Cibus Business Overview
Table 158. Cibus CRISPR & Cas Genes Product
Table 159. Cibus Revenue in CRISPR & Cas Genes Business (2016-2021) & (US$ Million)
Table 160. Cibus Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR & Cas Genes Market Share by Type: 2020 VS 2027
Figure 2. Vector-based Cas Features
Figure 3. DNA-free Cas Features
Figure 4. Cell Line Engineering Features
Figure 5. Global CRISPR & Cas Genes Market Share by Application: 2020 VS 2027
Figure 6. Biotechnology and Pharmaceutical Companies Case Studies
Figure 7. Academics and Government Research Institutes Case Studies
Figure 8. Contract Research Organizations (CROs) Case Studies
Figure 9. CRISPR & Cas Genes Report Years Considered
Figure 10. Global CRISPR & Cas Genes Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global CRISPR & Cas Genes Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global CRISPR & Cas Genes Market Share by Regions: 2020 VS 2027
Figure 13. Global CRISPR & Cas Genes Market Share by Regions (2022-2027)
Figure 14. Global CRISPR & Cas Genes Market Share by Players in 2020
Figure 15. Global Top CRISPR & Cas Genes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR & Cas Genes as of 2020
Figure 16. The Top 10 and 5 Players Market Share by CRISPR & Cas Genes Revenue in 2020
Figure 17. Global CRISPR & Cas Genes Revenue Market Share by Type (2016-2021)
Figure 18. Global CRISPR & Cas Genes Revenue Market Share by Type (2022-2027)
Figure 19. North America CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America CRISPR & Cas Genes Market Share by Type (2016-2027)
Figure 21. North America CRISPR & Cas Genes Market Share by Application (2016-2027)
Figure 22. North America CRISPR & Cas Genes Market Share by Country (2016-2027)
Figure 23. United States CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe CRISPR & Cas Genes Market Share by Type (2016-2027)
Figure 27. Europe CRISPR & Cas Genes Market Share by Application (2016-2027)
Figure 28. Europe CRISPR & Cas Genes Market Share by Country (2016-2027)
Figure 29. Germany CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific CRISPR & Cas Genes Market Share by Type (2016-2027)
Figure 37. Asia-Pacific CRISPR & Cas Genes Market Share by Application (2016-2027)
Figure 38. Asia-Pacific CRISPR & Cas Genes Market Share by Region (2016-2027)
Figure 39. China CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America CRISPR & Cas Genes Market Share by Type (2016-2027)
Figure 47. Latin America CRISPR & Cas Genes Market Share by Application (2016-2027)
Figure 48. Latin America CRISPR & Cas Genes Market Share by Country (2016-2027)
Figure 49. Mexico CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa CRISPR & Cas Genes Market Share by Type (2016-2027)
Figure 53. Middle East & Africa CRISPR & Cas Genes Market Share by Application (2016-2027)
Figure 54. Middle East & Africa CRISPR & Cas Genes Market Share by Country (2016-2027)
Figure 55. Turkey CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE CRISPR & Cas Genes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. CRISPR Therapeutics Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 60. Addgene Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 61. Caribou Biosciences, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 62. Cellectis Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 63. Editas Medicine, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 64. Egenesis Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 65. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 66. Horizon Discovery Group Plc Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 67. Genscrip Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 68. Danaher Corporation Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 69. Intellia Therapeutics, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 70. Lonza Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 71. Merck KGaA Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 72. New England BioLabs Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 73. Takara Bio, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 74. Synthego Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 75. Mammoth Biosciences Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 76. Inscripta, Inc. Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 77. Cibus Revenue Growth Rate in CRISPR & Cas Genes Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
CRISPR＆CRISPR関連（Cas）遺伝子のグローバル市場2021 Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid. The CRISPR/Cas system is a pro…- 世界のCRISPRベース治療法市場規模・現状・予測（2021年-2027年） CRISPR‐based genome editing technology has become an important potential therapeutic tool for various diseases. Market Analysis and Insights: Global CRISPR-Based Therapeutics Market The global CRISPR-Based Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in …
- 世界の合成遺伝子市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Synthetic Genes Market The global Synthetic Genes market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a bri…
- 世界のCRISPRゲノム編集市場規模・現状・予測（2021年-2027年） CRISPR Genome editing is a group of technologies that give scientists the ability to change CRISPR. Market Analysis and Insights: Global CRISPR Genome Editing Market The global CRISPR Genome Editing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of X…
- 世界のパッケージング受託機関(CRO)市場規模・現状・予測（2021年-2027年） Contract Packaging Organizations (CPOs) provide manufacturing (CMOs) and packaging (CPOs) services to Pharmaceutical Manufacturers on a contract basis. Just as with any industry, the contract manufacturing process and packaging process need to combine accuracy with efficiency to maintain profitabili…